BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28688279)

  • 41. Synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory potential of hydrazide based Schiff bases.
    Rahim F; Ullah H; Taha M; Wadood A; Javed MT; Rehman W; Nawaz M; Ashraf M; Ali M; Sajid M; Ali F; Khan MN; Khan KM
    Bioorg Chem; 2016 Oct; 68():30-40. PubMed ID: 27441832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
    Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
    Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.
    Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M
    Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study.
    Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
    Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
    Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
    Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii.
    Liu YM; Feng YD; Lu X; Nie JB; Li W; Wang LN; Tian LJ; Liu QH
    Eur J Med Chem; 2017 Sep; 137():280-291. PubMed ID: 28605675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases.
    Heller L; Schwarz S; Weber BA; Csuk R
    Arch Pharm (Weinheim); 2014 Oct; 347(10):707-16. PubMed ID: 25042600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
    Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
    Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
    Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
    Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors.
    Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant.
    de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.